The Tennessee Clinical and Translational Science Institute (TN-CTSI), the University of Tennessee Health Science Center’s newest research institute, recently awarded four pilot grants to collaborative research groups in support of new projects aimed at addressing the most-pressing health needs in the Southern United States. The 2019 TN-CTSI Pilot Project winners and their project titles are:… Read More
Just one year since its inception, the Clinical Trials Network of Tennessee (CTN2) has secured contracts to work with nine clinical sites across the state and has enrolled over 20 Tennesseans as patients in their trials. The innovative clinical trials network aims to provide new therapeutics and medical devices with the overarching goal of improving… Read More
Newly published results from a multinational study co-authored by Kenneth Ataga, MD, director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) and the Memphis Consortium for Sickle Cell Disease and Non-Malignant Hematology Research, indicated voxelotor, a novel experimental drug for sickle cell disease, reduced anemia and boosted… Read More
Retinal neovascularization (RNV) occurs when new blood vessels grow on the surface of the retina. While wound repair in the skin and many other tissues involves neovascularization, in the eye, neovascularization can cause severe vision loss and blindness. Nikhlesh K. Singh, DVM, PhD, assistant professor in the Department of Physiology in the College of Medicine at… Read More
Memphian and prostate cancer survivor Kenneth Carpenter understands the power of education and conversation. “When I was diagnosed, I knew I needed to educate myself on prostate cancer and start talking about it,” Carpenter said. “I needed to ‘man up to prostate cancer.’ Men, in particular African-American men, are quiet about their health, and are… Read More